stockrowHarmony Biosciences Holdings, Inc.
HRMY Healthcare Biotechnology
Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024.
- Revenue
- +12.3%
- EPS
- −6.24%
- Free cash flow
- −29.4%
- Total debt
- −11.5%
Quarter to September 2026, against a year earlier
Follow HRMY
Alert me
Harmony Biosciences Holdings, Inc. (HRMY) Net margin
Harmony Biosciences Holdings, Inc.'s net margin over the twelve months to 30 September 2026 was 18.1%, down 0.2 percentage points from fiscal 2025 (18.3%). Over the past ten years it has ranged from −3,122.7% (fiscal 2019) to 41.4% (fiscal 2022); the current reading is higher than 63% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 18.3% | (2.09) |
| FY2024 | 20.4% | (1.78) |
| FY2023 | 22.1% | (19.30) |
| FY2022 | 41.4% | 30.11 |
| FY2021 | 11.3% | 51.30 |
| FY2020 | −40.0% | 3,082.77 |
| FY2019 | −3,122.7% | (3,122.74) |
| FY2018 | 0.00% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | 17.9% | (10.95) |
| Jun 2026 | 28.9% | 13.79 |
| Mar 2026 | 15.1% | 5.86 |
| Dec 2025 | 9.22% | (12.02) |
| 25 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | 18.1% |
| REPL Replimune Group, Inc. compare | 0.00% |
| TRAX First Tracks Biotherapeutics, Inc. compare | 0.00% |
| MAZE Maze Therapeutics, Inc. compare | 0.00% |
| TRVI Trevi Therapeutics, Inc. compare | 0.00% |
| FTRE Fortrea Holdings Inc. compare | −2.58% |
| SRPT Sarepta Therapeutics, Inc. compare | −5.86% |
| VIR Vir Biotechnology, Inc. compare | −61.0% |
| MESO Mesoblast Limited compare | −1,091.7% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 1.14% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue